Αποτελέσματα Αναζήτησης
27 Νοε 2020 · This review has highlighted reported curative antiviral drugs and broad-spectrum antibiotics (both traditional and orthodox) used in the treatment of SARS-CoV-2; their chemistry, botanical sources, and active components as well as possible clinical trials and safety information.
- Table 1
ATV inhibits SARS-CoV-2 replication, alone or in combination...
- Open in a Separate Window
PMC full text: Int Immunopharmacol. 2021 Jan; 90: 107228....
- Table 1
9 Σεπ 2020 · On January 9, 2020, the Chinese Center for Disease Control and Prevention reported that a new coronavirus (SARS-CoV-2) has been identified as the causative agent of respiratory disease, later called COVID-19 (CoronaVirusDisease-19) ( Zhu et al., 2020 ).
15 Απρ 2024 · Originally developed for the treatment of HCV infection and Ebola virus disease, remdesivir also demonstrated antiviral activity against SARS-CoV and MERS-CoV in vivo 138,139.
28 Ιαν 2021 · To eliminate SARS-CoV-2 infection, several physicians have repurposed Ebola, SARS-CoV, MERS-CoV, and HIV medications. The clinical treatment of the disorder also uses IL-6 and convalescent therapy .
27 Οκτ 2021 · Highly effective therapeutic agents directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19, are needed for these high-risk persons.
26 Μαΐ 2023 · Paxlovid. What is it? Paxlovid is Pfizer’s brand name for an antiviral oral medication (in pill form) that combines two generic drugs, nirmatrelvir and ritonavir.
15 Ιουλ 2024 · Nirmatrelvir–ritonavir is an important therapy for those with COVID-19, especially for outpatients and patients with a high risk of poor outcomes. Nirmatrelvir–ritonavir has long been recommended by living guidelines for mild-to-moderate COVID-19, following its established effects in decreasing mortality and health-care costs.
